Looks like there`s been an error while trying to load this page.
Our team has been notified but please contact us using the email support widget if the problem persists.
Metrics | Range | Conclusion |
---|---|---|
Selected LTM Pb Multiple | 2.7x - 3.0x | 2.9x |
Historical Pb Multiple | 1.5x - 3.2x | 2.2x |
Fair Value | €143.23 - €158.31 | €150.77 |
Upside | -16.6% - -7.9% | -12.2% |
Benchmarks | - | Full Ticker |
Bayer Aktiengesellschaft | - | DB:BAYN |
Ipsen S.A. | - | ENXTPA:IPN |
Merck KGaA | - | DB:MRK |
GSK plc | - | DB:GS71 |
Sandoz Group AG | - | SWX:SDZ |
UCB SA | - | DB:UNC |
Select Price / Book Ratio | ||||||||
Benchmark Companies | ||||||||
BAYN | IPN | MRK | GS71 | SDZ | UNC | |||
DB:BAYN | ENXTPA:IPN | DB:MRK | DB:GS71 | SWX:SDZ | DB:UNC | |||
Historical Net Income Growth | ||||||||
5Y CAGR | NM- | NM- | 16.5% | -11.1% | NM- | 6.2% | ||
3Y CAGR | NM- | -17.4% | -3.1% | -8.1% | NM- | 0.3% | ||
Latest Twelve Months | -4.3% | -42.3% | 3.5% | -29.7% | -100.0% | 210.5% | ||
Historical Net Income Profit Margin | ||||||||
5 Year Average Margin | -4.3% | 17.3% | 13.6% | 24.2% | 3.8% | 12.4% | ||
Prior Fiscal Year | -6.2% | 18.7% | 13.5% | 16.2% | 0.8% | 6.6% | ||
Latest Fiscal Year | -5.5% | 10.0% | 13.1% | 8.2% | 0.0% | 17.3% | ||
Latest Twelve Months | -7.0% | 10.0% | 13.2% | 10.0% | 0.0% | 17.3% | ||
Return on Equity | ||||||||
5 Year Average Margin | -7.5% | 16.3% | 12.0% | 33.6% | 2.8% | 7.3% | ||
Prior Fiscal Year | -8.2% | 17.2% | 10.7% | 41.2% | 0.9% | 3.8% | ||
Latest Twelve Months | -9.6% | 8.9% | 9.7% | 22.5% | 0.0% | 11.2% | ||
Next Fiscal Year | 13.1% | 19.0% | 12.1% | 42.8% | 15.7% | 13.3% | ||
Two Fiscal Years Forward | 12.2% | 17.4% | 12.2% | 37.2% | 16.1% | 15.7% | ||
Current Trading Multiples | ||||||||
Price / LTM Sales | 0.6x | 2.4x | 2.3x | 1.8x | 2.3x | 5.3x | ||
Price / LTM EPS | -8.3x | 24.5x | 17.4x | 18.1x | NA | 30.5x | ||
Price / Book | 0.8x | 2.1x | 1.6x | 4.0x | 3.0x | 3.2x | ||
Price / Fwd Book | 0.7x | 1.8x | 1.5x | 3.2x | 2.6x | 3.0x | ||
Low | Mid | High | ||||||
Benchmark P/B Ratio | 0.8x | 2.1x | 4.0x | |||||
Historical P/B Ratio | 1.5x | 2.2x | 3.2x | |||||
Selected P/B Multiple | 2.7x | 2.9x | 3.0x | |||||
(x) Book Value | 10,029 | 10,029 | 10,029 |
Equity Value | |||||||
Benchmark Companies | |||||||
(in millions) | BAYN | IPN | MRK | GS71 | SDZ | UNC | |
Value of Common Equity | 26,899 | 8,728 | 49,021 | 57,231 | 24,122 | 32,649 | |
(/) Shares Outstanding | 982.4 | 82.6 | 434.8 | 4,046.1 | 430.7 | 190.0 | |
Implied Stock Price | 27.38 | 105.70 | 112.75 | 14.14 | 56.01 | 171.80 | |
FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 0.87 | 1.25 | 1.00 | |
Implied Stock Price (Trading Cur) | 27.38 | 105.70 | 112.75 | 16.34 | 44.63 | 171.80 | |
Trading Currency | EUR | EUR | EUR | EUR | CHF | EUR | |
FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 0.87 | 1.25 | 1.00 |